Fatty acid oxidation defects
|
group |
|
Disease or Syndrome
|
2
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Increased Cellularity Present
|
disease |
|
Neoplastic Process
|
21
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Undifferentiated carcinoma of nasopharynx
|
disease |
|
Neoplastic Process
|
23
|
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Acute-Phase Reaction
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
24
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Leukostasis
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
25
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Alcoholic Steatohepatitis
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
30
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Asymmetric Septal Hypertrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Disease or Syndrome
|
31
|
7
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Persistent Hyperplastic Primary Vitreous
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Congenital Abnormality
|
33
|
4
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Symptoms of stress
|
phenotype |
|
Sign or Symptom
|
33
|
5
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Lipoidosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
44
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Intestinal Polyps
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Anatomical Abnormality
|
48
|
1
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
CATARACT, MARNER TYPE
|
disease |
Eye Diseases
|
Disease or Syndrome
|
63
|
5
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Colon adenoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
63
|
1
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Alcohol withdrawal syndrome
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Disease or Syndrome
|
67
|
6
|
0.010 |
None |
< 0.001 |
1 |
|
2015 |
2015 |
Cardiac Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
88
|
11
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Rectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
93
|
21
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Acne Vulgaris
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
94
|
37
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Myocardial Diseases, Secondary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
101
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Long QT Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Disease or Syndrome
|
105
|
349
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cardiomyopathies, Primary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
108
|
1
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Ketosis
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
119
|
11
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Weight Gain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
124
|
12
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
neurofibroma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
125
|
5
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Cavernous Hemangioma of Brain
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Anatomical Abnormality
|
127
|
43
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Neurofibromatoses
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
135
|
16
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |